Announcements Trials
Browse Landscape

Phase

Phase 2 21Phase 1 9Phase 3 8Phase NA 5Phase 1/2 5Phase 2/3 3Phase 4 2

Status

Unknown 2

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Tumor-Agnostic 2

Conditions

Breast Neoplasms 3Neoplasms 2NSCLC 2Lymphoma, Non-Hodgkin 2Carcinoma, Non-Small-Cell Lung 2Adenocarcinoma 2Solid Tumor Regardless of Localization and Stage 1Patient Acceptance of Health Care 1Pancreatic Neoplasms 1Pain 1Oropharyngeal Neoplasms 1Neoplasms, Second Primary 1Multiple Myeloma 1Lymphoma, Extranodal NK-T-Cell 1Localized Advanced Rectal Adenocarcinoma 1Liver Neoplasms 1HER-2 Negative Breast Cancer 1Gastrointestinal Neoplasms 1Esophageal Neoplasms 1Colorectal Neoplasms 1Acute Kidney Injury 1

Interventions

Dexamethasone 8Oxycodone 6Epoetin Alfa 5Propofol 4Palonosetron 4Meropenem 4Zoledronic Acid 3Vancomycin 3Sevoflurane 3Ondansetron 3Naloxone 3Everolimus 3Ciprofloxacin 3Cholecalciferol 3Ceftazidime 3Cefepime 3Calcium Dobesilate 3Bevacizumab 3Aspirin 3Aprepitant 3peginterferon alfa-2a 2edoxaban 2apixaban 2apatinib 2Vitamin B 12 2Vincristine 2Tobacco Use Cessation Devices 2Teicoplanin 2Tablets 2Surgical Procedures, Operative 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 4 × Neoplasms × Drug Therapy × Clear all
NCT00894153 2012-04-09

p53 Gene Therapy for Head and Neck Malignant Tumors in Advanced Stage

Shenzhen SiBiono GeneTech Co.,Ltd

Phase 4 Unknown
1,200 enrolled
Tumor-Agnostic

Neoplasms

NCT00902083 2012-04-09

rAd-p53

Shenzhen SiBiono GeneTech Co.,Ltd

Phase 4 Unknown
600 enrolled
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡